2026 Biologics Formulation Development Intern (PhD) jobs in United States
cer-icon
Apply on Employer Site
company-logo

AbbVie · 4 hours ago

2026 Biologics Formulation Development Intern (PhD)

positionNorth Chicago, IL
timeInternship
remoteOnsite
seniorityIntern
workcardStart in 2026 Summer

AbbVie is a company dedicated to discovering and delivering innovative medicines to tackle serious health issues. They are seeking a Biologics Formulation Development Intern to support formulation development experiments, advanced modeling, and statistical analyses during the summer internship.

BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Design and execution of formulation development and characterization experiments
Advanced kinetic modeling and molecular dynamics simulations
Design of Experiments (DoE) and statistical data analyses
Authoring technical reports and scientific presentations

Qualification

Formulation developmentKinetic modelingMolecular dynamics simulationsDesign of Experiments (DoE)Statistical data analysesTherapeutic proteins formulationCommunicationTeamworkProblem-solvingTime management

Required

Currently enrolled in university, pursuing a PhD in pharmaceutical sciences, chemistry, chemical engineering or other related field
Must be enrolled in university for at least one semester following the internship

Preferred

Expected graduation date between December 2026 – June 2027
Advanced coursework in pharmaceutical, physical chemistry, biophysics, biochemistry, thermodynamics, chemical kinetics, mathematics and/or statistics
Working experience with therapeutic proteins formulation, drug delivery and/or biophysical characterization
Strong communication, teamwork, problem-solving, and time management skills

Benefits

Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time

Company

AbbVie

twittertwittertwitter
Glassdoor3.9
company-logo
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
dateFounded in 2013
location
North Chicago, Illinois, USA
people-size10001+ employees
web-link
https://www.abbvie.com

H1B Sponsorship

AbbVie has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)

Funding

Current Stage
Public Company
Total Funding
$15B
2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO

Leadership Team

leader-logo
Robert Michael
Chairman of the Board and Chief Executive Officer
linkedin
leader-logo
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
linkedin

Recent News

TradingView
Key facts: AbbVie to invest $100B in U.S. research; Phase 3 trial shows progress
2026-01-18
FiercePharma
JPM26, Day 3: AbbVie touts 'clear line of sight' to continued growth into 2030s
2026-01-17
FiercePharma
Fierce Pharma Asia—AbbVie’s bispecific play, Illumina’s China import efforts and pharma execs’ JPM comments
2026-01-17
Company data provided by crunchbase